Folks, right here. Think about that. A halo, a pitch. You put your money in or watch for warning signs . Sheila and seema have both sides of the coin today. And Timothy Geithner, the back story, folks, former treasury secretary, key player in the financial crisis, has a new job now, but wait until hear the backstory and st. Loueve liesma it. Halo or pitch fork . Seema is such a sweetheart, should have been two halos. I know what they were trying to do. No way she could be a devil. We have a recordbreaking day down here, ty. The dow and s p crossing big, big numbers, 16,000 for the dowp. Right now it is up 39 points on todays trading session, but its up 144 from the march 2009 bottom. The s p hit the 1800 mark for the first time ever, it is now slightly to the downside. Its kind of hugging that 1800 mark. But it is up 165 since that 09 bottom. The nasdaq inching ever closer to 4,000. That index is down 4. 5 points today but its up 214 since march of 09. The big question now is, where do
Avid Bioservices (NASDAQ:CDMO – Get Free Report) and TetraLogic Pharmaceuticals (OTCMKTS:TLOG – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Insider & Institutional Ownership 0.0% of TetraLogic Pharmaceuticals […]
Morphic (NASDAQ:MORF – Get Rating) and TetraLogic Pharmaceuticals (OTCMKTS:TLOG – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability. Earnings & Valuation This table compares Morphic and TetraLogic Pharmaceuticals’ gross […]
Morphic (NASDAQ:MORF – Get Rating) and TetraLogic Pharmaceuticals (OTCMKTS:TLOG – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership. Profitability This table compares Morphic and TetraLogic Pharmaceuticals’ net margins, return […]